Iron and innate antimicrobial immunity—Depriving the pathogen, defending the host

Journal of Trace Elements in Medicine and Biology

Volumn 48, Issue , 2018, Pages 118-133

  Nairz, Manfred ^a   Dichtl, Stefanie ^a   Schroll, Andrea ^a   Haschka, David ^a   Tymoszuk, Piotr ^a   Theurl, Igor ^a   Weiss, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Anaemia of inflammation; Ferroportin; Hepcidin; Hypoferraemia; Infection; Iron; Macrophage

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; CCAAT ENHANCER BINDING PROTEIN DELTA; CD163 ANTIGEN; FERROPORTIN 1; GAMMA INTERFERON; HAPTOGLOBIN; HEME OXYGENASE 1; HEMOPEXIN; HEPCIDIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; IRON; MYELOPID; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

CHLAMYDIA; ENZYME ACTIVATION; ENZYME INHIBITION; HEMOLYSIS; HUMAN; INNATE IMMUNITY; INTERNALIZATION; INTESTINE CELL; IRON HOMEOSTASIS; IRON METABOLISM; KLEBSIELLA; LISTERIA MONOCYTOGENES; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TH1 CELL; YERSINIA; ANIMAL; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOGENICITY;

ANIMALS; ANTI-BACTERIAL AGENTS; HUMANS; IMMUNITY, INNATE; IRON; KLEBSIELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; YERSINIA;

EID: 85044460057     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2018.03.007     Document Type: Review

References (319)

1. Weiss, G., Iron and immunity: a double-edged sword. Eur. J. Clin. Invest. 32:Suppl. 1 (2002), 70–78.
2. Oexle, H., Gnaiger, E., Weiss, G., Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim. Biophys. Acta 1413:3 (1999), 99–107.
3. Volani, C., Doerrier, C., Demetz, E., Haschka, D., Paglia, G., Lavdas, A.A., Gnaiger, E., Weiss, G., Dietary iron loading negatively affects liver mitochondrial function. Metallomics 9:11 (2017), 1634–1644.
4. Muckenthaler, M.U., Rivella, S., Hentze, M.W., Galy, B., A red carpet for iron metabolism. Cell 168:3 (2017), 344–361.
5. Weinberg, E.D., Iron and infection. Microbiol. Rev. 42:1 (1978), 45–66.
6. Cabantchik, Z.I., Kakhlon, O., Epsztejn, S., Zanninelli, G., Breuer, W., Intracellular and extracellular labile iron pools. Adv. Exp. Med. Biol. 509 (2002), 55–75.
7. Andrews, S.C., Robinson, A.K., Rodriguez-Quinones, F., Bacterial iron homeostasis. FEMS Microbiol. Rev. 27:2–3 (2003), 215–237.
8. Breuer, W., Shvartsman, M., Cabantchik, Z.I., Intracellular labile iron. Int. J. Biochem. Cell Biol. 40:3 (2008), 350–354.
9. Halsey, T.A., Vazquez-Torres, A., Gravdahl, D.J., Fang, F.C., Libby, S.J., The ferritin-like Dps protein is required for Salmonella enterica serovar Typhimurium oxidative stress resistance and virulence. Infect. Immun. 72:2 (2004), 1155–1158.
10. Knutson, M.D., Vafa, M.R., Haile, D.J., Wessling-Resnick, M., Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102:12 (2003), 4191–4197.
11. Theurl, M., Song, D., Clark, E., Sterling, J., Grieco, S., Altamura, S., Galy, B., Hentze, M., Muckenthaler, M.U., Dunaief, J.L., Mice with hepcidin-resistant ferroportin accumulate iron in the retina. FASEB J. 30:2 (2015), 813–823.
12. Epsztejn, S., Glickstein, H., Picard, V., Slotki, I.N., Breuer, W., Beaumont, C., Cabantchik, Z.I., H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94:10 (1999), 3593–3603.
13. Keel, S.B., Doty, R.T., Yang, Z., Quigley, J.G., Chen, J., Knoblaugh, S., Kingsley, P.D., De Domenico, I., Vaughn, M.B., Kaplan, J., Palis, J., Abkowitz, J.L., A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 319:5864 (2008), 825–828.
14. Frawley, E.R., Crouch, M.L., Bingham-Ramos, L.K., Robbins, H.F., Wang, W., Wright, G.D., Fang, F.C., Iron and citrate export by a major facilitator superfamily pump regulates metabolism and stress resistance in Salmonella Typhimurium. Proc. Natl. Acad. Sci. U. S. A. 110:29 (2013), 12054–12059.
15. De Groote, M.A., Granger, D., Xu, Y., Campbell, G., Prince, R., Fang, F.C., Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc. Natl. Acad. Sci. U. S. A. 92:14 (1995), 6399–6403.
16. De Groote, M.A., Ochsner, U.A., Shiloh, M.U., Nathan, C., McCord, J.M., Dinauer, M.C., Libby, S.J., Vazquez-Torres, A., Xu, Y., Fang, F.C., Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 94:25 (1997), 13997–14001.
17. Henard, C.A., Vazquez-Torres, A., DksA-dependent resistance of Salmonella enterica serovar Typhimurium against the antimicrobial activity of inducible nitric oxide synthase. Infect. Immun. 80:4 (2012), 1373–1380.
18. Koskenkorva-Frank, T.S., Weiss, G., Koppenol, W.H., Burckhardt, S., The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic. Biol. Med. 65 (2013), 1174–1194.
19. Papanikolaou, G., Pantopoulos, K., Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202:2 (2005), 199–211.
20. Andrews, N.C., Schmidt, P.J., Iron homeostasis. Annu. Rev. Physiol. 69 (2007), 69–85.
21. Khan, A.A., Quigley, J.G., Heme and FLVCR-related transporter families SLC48 and SLC49. Mol. Aspects Med. 34:2–3 (2013), 669–682.
22. Shayeghi, M., Latunde-Dada, G.O., Oakhill, J.S., Laftah, A.H., Takeuchi, K., Halliday, N., Khan, Y., Warley, A., McCann, F.E., Hider, R.C., Frazer, D.M., Anderson, G.J., Vulpe, C.D., Simpson, R.J., McKie, A.T., Identification of an intestinal heme transporter. Cell 122:5 (2005), 789–801.
23. Latunde-Dada, G.O., Takeuchi, K., Simpson, R.J., McKie, A.T., Haem carrier protein 1 (HCP1): expression and functional studies in cultured cells. FEBS Lett. 580:30 (2006), 6865–6870.
24. Qiu, A., Jansen, M., Sakaris, A., Min, S.H., Chattopadhyay, S., Tsai, E., Sandoval, C., Zhao, R., Akabas, M.H., Goldman, I.D., Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127:5 (2006), 917–928.
25. Gunshin, H., Mackenzie, B., Berger, U.V., Gunshin, Y., Romero, M.F., Boron, W.F., Nussberger, S., Gollan, J.L., Hediger, M.A., Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:6641 (1997), 482–488.
26. Fleming, M.D., Trenor, C.C. 3rd, Su, M.A., Foernzler, D., Beier, D.R., Dietrich, W.F., Andrews, N.C., Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16:4 (1997), 383–386.
27. McKie, A.T., Barrow, D., Latunde-Dada, G.O., Rolfs, A., Sager, G., Mudaly, E., Mudaly, M., Richardson, C., Barlow, D., Bomford, A., Peters, T.J., Raja, K.B., Shirali, S., Hediger, M.A., Farzaneh, F., Simpson, R.J., An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291:5509 (2001), 1755–1759.
28. Frey, A.G., Nandal, A., Park, J.H., Smith, P.M., Yabe, T., Ryu, M.S., Ghosh, M.C., Lee, J., Rouault, T.A., Park, M.H., Philpott, C.C., Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase. Proc. Natl. Acad. Sci. U. S. A. 111:22 (2014), 8031–8036.
29. Lane, D.J., Richardson, D.R., Chaperone turns gatekeeper: PCBP2 and DMT1 form an iron-transport pipeline. Biochem. J 462:1 (2014), e1–3.
30. Shi, H., Bencze, K.Z., Stemmler, T.L., Philpott, C.C., A cytosolic iron chaperone that delivers iron to ferritin. Science 320:5880 (2008), 1207–1210.
31. Yanatori, I., Richardson, D.R., Imada, K., Kishi, F., Iron export through the transporter ferroportin 1 is modulated by the iron chaperone PCBP2. J. Biol. Chem. 291:33 (2016), 17303–17318.
32. Zoller, H., Theurl, I., Koch, R.O., McKie, A.T., Vogel, W., Weiss, G., Duodenal cytochrome b and hephaestin expression in patients with iron deficiency and hemochromatosis. Gastroenterology 125:3 (2003), 746–754.
33. Chen, H., Su, T., Attieh, Z.K., Fox, T.C., McKie, A.T., Anderson, G.J., Vulpe, C.D., Systemic regulation of Hephaestin and Ireg1 revealed in studies of genetic and nutritional iron deficiency. Blood 102:5 (2003), 1893–1899.
34. Ohgami, R.S., Campagna, D.R., Greer, E.L., Antiochos, B., McDonald, A., Chen, J., Sharp, J.J., Fujiwara, Y., Barker, J.E., Fleming, M.D., Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat. Genet. 37:11 (2005), 1264–1269.
35. Chen, H., Attieh, Z.K., Su, T., Syed, B.A., Gao, H., Alaeddine, R.M., Fox, T.C., Usta, J., Naylor, C.E., Evans, R.W., McKie, A.T., Anderson, G.J., Vulpe, C.D., Hephaestin is a ferroxidase that maintains partial activity in sex-linked anemia mice. Blood 103:10 (2004), 3933–3939.
36. Finkenstedt, A., Wolf, E., Hofner, E., Gasser, B.I., Bosch, S., Bakry, R., Creus, M., Kremser, C., Schocke, M., Theurl, M., Moser, P., Schranz, M., Bonn, G., Poewe, W., Vogel, W., Janecke, A.R., Zoller, H., Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation. J. Hepatol. 53:6 (2010), 1101–1107.
37. Lambe, T., Simpson, R.J., Dawson, S., Bouriez-Jones, T., Crockford, T.L., Lepherd, M., Latunde-Dada, G.O., Robinson, H., Raja, K.B., Campagna, D.R., Villarreal, G. Jr., Ellory, J.C., Goodnow, C.C., Fleming, M.D., McKie, A.T., Cornall, R.J., Identification of a Steap3 endosomal targeting motif essential for normal iron metabolism. Blood 113:8 (2009), 1805–1808.
38. Hubert, N., Hentze, M.W., Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc. Natl. Acad. Sci. U. S. A. 99:19 (2002), 12345–12350.
39. Gruenheid, S., Canonne-Hergaux, F., Gauthier, S., Hackam, D.J., Grinstein, S., Gros, P., The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J. Exp. Med. 189:5 (1999), 831–841.
40. Schumann, K., Ettle, T., Szegner, B., Elsenhans, B., Solomons, N.W., On risks and benefits of iron supplementation recommendations for iron intake revisited. J. Trace Elem. Med. Biol. 21:3 (2007), 147–168.
41. Nairz, M., Weiss, G., Molecular and clinical aspects of iron homeostasis: from anemia to hemochromatosis. Wien. Klin. Wochenschr. 118:15–16 (2006), 442–462.
42. Evstatiev, R., Gasche, C., Iron sensing and signalling. Gut 61:6 (2012), 933–952.
43. Theurl, I., Fritsche, G., Ludwiczek, S., Garimorth, K., Bellmann-Weiler, R., Weiss, G., The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections. Biometals 18:4 (2005), 359–367.
44. Ganz, T., Macrophages and systemic iron homeostasis. J. Innate Immun. 4:5–6 (2012), 446–453.
45. Gottlieb, Y., Topaz, O., Cohen, L.A., Yakov, L.D., Haber, T., Morgenstern, A., Weiss, A., Chait Berman, K., Fibach, E., Meyron-Holtz, E.G., Physiologically aged red blood cells undergo erythrophagocytosis in vivo but not in vitro. Haematologica 97:7 (2012), 994–1002.
46. Knutson, M.D., Oukka, M., Koss, L.M., Aydemir, F., Wessling-Resnick, M., Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc. Natl. Acad. Sci. U. S. A. 102:5 (2005), 1324–1328.
47. Rivera, S., Nemeth, E., Gabayan, V., Lopez, M.A., Farshidi, D., Ganz, T., Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106:6 (2005), 2196–2199.
48. Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T., Kaplan, J., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:5704 (2004), 2090–2093.
49. Camberlein, E., Abgueguen, E., Fatih, N., Canonne-Hergaux, F., Leroyer, P., Turlin, B., Ropert, M., Brissot, P., Loreal, O., Hepcidin induction limits mobilisation of splenic iron in a mouse model of secondary iron overload. Biochim. Biophys. Acta 1802:3 (2010), 339–346.
50. Galli, A., Bergamaschi, G., Recalde, H., Biasiotto, G., Santambrogio, P., Boggi, S., Levi, S., Arosio, P., Cazzola, M., Ferroportin gene silencing induces iron retention and enhances ferritin synthesis in human macrophages. Br. J. Haematol. 127:5 (2004), 598–603.
51. Meynard, D., Babitt, J.L., Lin, H.Y., The liver: conductor of systemic iron balance. Blood 123:2 (2013), 168–176.
52. Corradini, E., Meynard, D., Wu, Q., Chen, S., Ventura, P., Pietrangelo, A., Babitt, J.L., Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology 54:1 (2011), 273–284.
53. Schmidt, P.J., Toran, P.T., Giannetti, A.M., Bjorkman, P.J., Andrews, N.C., The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 7:3 (2008), 205–214.
54. Babitt, J.L., Huang, F.W., Wrighting, D.M., Xia, Y., Sidis, Y., Samad, T.A., Campagna, J.A., Chung, R.T., Schneyer, A.L., Woolf, C.J., Andrews, N.C., Lin, H.Y., Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38:5 (2006), 531–539.
55. D'Alessio, F., Hentze, M.W., Muckenthaler, M.U., The hemochromatosis proteins HFE TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. J. Hepatol. 57:5 (2012), 1052–1060.
56. Zhang, A.S., Xiong, S., Tsukamoto, H., Enns, C.A., Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood 103:4 (2004), 1509–1514.
57. Pietrangelo, A., Hereditary hemochromatosis–a new look at an old disease. N. Engl. J. Med. 350:23 (2004), 2383–2397.
58. Fleming, R.E., Ponka, P., Iron overload in human disease. N. Engl. J. Med. 366:4 (2012), 348–359.
59. Wallace, D.F., Summerville, L., Subramaniam, V.N., Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. Gastroenterology 132:1 (2007), 301–310.
60. Canali, S., Zumbrennen-Bullough, K.B., Core, A.B., Wang, C.Y., Nairz, M., Bouley, R., Swirski, F.K., Babitt, J.L., Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice. Blood 129:4 (2017), 405–414.
61. Andriopoulos, B. Jr., Corradini, E., Xia, Y., Faasse, S.A., Chen, S., Grgurevic, L., Knutson, M.D., Pietrangelo, A., Vukicevic, S., Lin, H.Y., Babitt, J.L., BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet. 41:4 (2009), 482–487.
62. Corradini, E., Rozier, M., Meynard, D., Odhiambo, A., Lin, H.Y., Feng, Q., Migas, M.C., Britton, R.S., Babitt, J.L., Fleming, R.E., Iron regulation of hepcidin despite attenuated Smad1, 5, 8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology 141:5 (2011), 1907–1914.
63. Babitt, J.L., Huang, F.W., Xia, Y., Sidis, Y., Andrews, N.C., Lin, H.Y., Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest. 117:7 (2007), 1933–1939.
64. Canali, S., Wang, C.Y., Zumbrennen-Bullough, K.B., Bayer, A., Babitt, J.L., Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6. Am. J. Hematol. 92:11 (2017), 1204–1213.
65. Koch, P.S., Olsavszky, V., Ulbrich, F., Sticht, C., Demory, A., Leibing, T., Henzler, T., Meyer, M., Zierow, J., Schneider, S., Breitkopf-Heinlein, K., Gaitantzi, H., Spencer-Dene, B., Arnold, B., Klapproth, K., Schledzewski, K., Goerdt, S., Geraud, C., Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis. Blood 129:4 (2016), 415–419.
66. Kautz, L., Jung, G., Valore, E.V., Rivella, S., Nemeth, E., Ganz, T., Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat. Genet. 46:7 (2014), 678–684.
67. Kautz, L., Jung, G., Du, X., Gabayan, V., Chapman, J., Nasoff, M., Nemeth, E., Ganz, T., Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia. Blood 126:17 (2015), 2031–2037.
68. Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., Haschka, D., Mitterstiller, A.M., Kleinsasser, A., Burtscher, M., Trubsbach, S., Murphy, A.T., Wroblewski, V., Witcher, D.R., Mleczko-Sanecka, K., Vecchi, C., Muckenthaler, M.U., Pietrangelo, A., Theurl, I., Weiss, G., Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. Gut 63:12 (2014), 1951–1959.
69. Nairz, M., Sonnweber, T., Schroll, A., Theurl, I., Weiss, G., The pleiotropic effects of erythropoietin in infection and inflammation. Microbes Infect. 14:3 (2012), 238–246.
70. Jelkmann, W., Molecular biology of erythropoietin. Intern. Med. 43:8 (2004), 649–659.
71. Sato, T., Maekawa, T., Watanabe, S., Tsuji, K., Nakahata, T., Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. J. Clin. Invest. 106:2 (2000), 263–270.
72. Dolznig, H., Habermann, B., Stangl, K., Deiner, E.M., Moriggl, R., Beug, H., Mullner, E.W., Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts. Curr. Biol. 12:13 (2002), 1076–1085.
73. Shanmugam, N.K., Trebicka, E., Fu, L.L., Shi, H.N., Cherayil, B.J., Intestinal inflammation modulates expression of the iron-regulating hormone hepcidin depending on erythropoietic activity and the commensal microbiota. J. Immunol. 193:3 (2014), 1398–1407.
74. Gammella, E., Diaz, V., Recalcati, S., Buratti, P., Samaja, M., Dey, S., Noguchi, C.T., Gassmann, M., Cairo, G., Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly. Am. J. Physiol. Regul. Integr. Comp. Physiol. 308:4 (2014), R330–5.
75. Pinto, J.P., Ribeiro, S., Pontes, H., Thowfeequ, S., Tosh, D., Carvalho, F., Porto, G., Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 111:12 (2008), 5727–5733.
76. Olsson, M., Oldenborg, P.A., CD47 on experimentally senescent murine RBCs inhibits phagocytosis following Fcgamma receptor-mediated but not scavenger receptor-mediated recognition by macrophages. Blood 112:10 (2008), 4259–4267.
77. Yi, T., Li, J., Chen, H., Wu, J., An, J., Xu, Y., Hu, Y., Lowell, C.A., Cyster, J.G., Splenic dendritic cells survey red blood cells for missing self-CD47 to trigger adaptive immune responses. Immunity 43:4 (2015), 764–775.
78. Oldenborg, P.A., Gresham, H.D., Lindberg, F.P., CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J. Exp. Med. 193:7 (2001), 855–862.
79. Terpstra, V., van Berkel, T.J., Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood 95:6 (2000), 2157–2163.
80. Theurl, M., Theurl, I., Hochegger, K., Obrist, P., Subramaniam, N., van Rooijen, N., Schuemann, K., Weiss, G., Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression. J. Mol. Med. (Berl.) 86:7 (2008), 825–835.
81. Ferris, C.D., Jaffrey, S.R., Sawa, A., Takahashi, M., Brady, S.D., Barrow, R.K., Tysoe, S.A., Wolosker, H., Baranano, D.E., Dore, S., Poss, K.D., Snyder, S.H., Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat. Cell Biol. 1:3 (1999), 152–157.
82. Gozzelino, R., Jeney, V., Soares, M.P., Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 50 (2010), 323–354.
83. Onyiah, J.C., Sheikh, S.Z., Maharshak, N., Steinbach, E.C., Russo, S.M., Kobayashi, T., Mackey, L.C., Hansen, J.J., Moeser, A.J., Rawls, J.F., Borst, L.B., Otterbein, L.E., Plevy, S.E., Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance. Gastroenterology 144:4 (2013), 789–798.
84. Zuckerbraun, B.S., Billiar, T.R., Otterbein, S.L., Kim, P.K., Liu, F., Choi, A.M., Bach, F.H., Otterbein, L.E., Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J. Exp. Med. 198:11 (2003), 1707–1716.
85. Poss, K.D., Tonegawa, S., Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U. S. A. 94:20 (1997), 10919–10924.
86. Torti, F.M., Torti, S.V., Regulation of ferritin genes and protein. Blood 99:10 (2002), 3505–3516.
87. Miller, L.L., Miller, S.C., Torti, S.V., Tsuji, Y., Torti, F.M., Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc. Natl. Acad. Sci. U. S. A. 88:11 (1991), 4946–4950.
88. Pham, C.G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., Torti, F.M., Torti, S.V., Franzoso, G., Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119:4 (2004), 529–542.
89. Weiss, G., Goossen, B., Doppler, W., Fuchs, D., Pantopoulos, K., Werner-Felmayer, G., Wachter, H., Hentze, M.W., Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J. 12:9 (1993), 3651–3657.
90. Pantopoulos, K., Hentze, M.W., Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J. 14:12 (1995), 2917–2924.
91. Rogers, J.T., Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 87:6 (1996), 2525–2537.
92. Han, J., Seaman, W.E., Di, X., Wang, W., Willingham, M., Torti, F.M., Torti, S.V., Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells. PLoS One, 6(8), 2011, e23800.
93. Chen, T.T., Li, L., Chung, D.H., Allen, C.D., Torti, S.V., Torti, F.M., Cyster, J.G., Chen, C.Y., Brodsky, F.M., Niemi, E.C., Nakamura, M.C., Seaman, W.E., Daws, M.R., TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J. Exp. Med. 202:7 (2005), 955–965.
94. Li, J.Y., Paragas, N., Ned, R.M., Qiu, A., Viltard, M., Leete, T., Drexler, I.R., Chen, X., Sanna-Cherchi, S., Mohammed, F., Williams, D., Lin, C.S., Schmidt-Ott, K.M., Andrews, N.C., Barasch, J., Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev. Cell 16:1 (2009), 35–46.
95. Mendes-Jorge, L., Ramos, D., Valenca, A., Lopez-Luppo, M., Pires, V.M., Catita, J., Nacher, V., Navarro, M., Carretero, A., Rodriguez-Baeza, A., Ruberte, J., L-ferritin binding to scara5: a new iron traffic pathway potentially implicated in retinopathy. PLoS One, 9(9), 2014, e106974.
96. Cohen, L.A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D.L., Crooks, D.R., Sougrat, R., Morgenstern, A., Galy, B., Hentze, M.W., Lazaro, F.J., Rouault, T.A., Meyron-Holtz, E.G., Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 116:9 (2010), 1574–1584.
97. Wang, W., Knovich, M.A., Coffman, L.G., Torti, F.M., Torti, S.V., Serum ferritin: past present and future. Biochim. Biophys. Acta 1800:8 (2010), 760–769.
98. Ryc, M., Wagner, B., Wagner, M., Petras, P., Havlicek, J., Binding of horse-spleen ferritin to group A streptococci. Microbios 4:181S (1985), 261–269.
99. Segond, D., Abi Khalil, E., Buisson, C., Daou, N., Kallassy, M., Lereclus, D., Arosio, P., Bou-Abdallah, F., Nielsen Le Roux, C., Iron acquisition in Bacillus cereus: the roles of IlsA and bacillibactin in exogenous ferritin iron mobilization. PLoS Pathog., 10(2), 2014, e1003935.
100. Larson, J.A., Howie, H.L., So, M., Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source. Mol. Microbiol. 53:3 (2004), 807–820.
101. Jin, B., Newton, S.M., Shao, Y., Jiang, X., Charbit, A., Klebba, P.E., Iron acquisition systems for ferric hydroxamates haemin and haemoglobin in Listeria monocytogenes. Mol. Microbiol. 59:4 (2006), 1185–1198.
102. Nairz, M., Ferring-Appel, D., Casarrubea, D., Sonnweber, T., Viatte, L., Schroll, A., Haschka, D., Fang, F.C., Hentze, M.W., Weiss, G., Galy, B., Iron regulatory proteins mediate host resistance to Salmonella infection. Cell Host Microbe 18:2 (2015), 254–261.
103. Marro, S., Chiabrando, D., Messana, E., Stolte, J., Turco, E., Tolosano, E., Muckenthaler, M.U., Heme controls ferroportin1 (FPN1) transcription involving Bach1 Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica 95:8 (2010), 1261–1268.
104. Zoller, H., Theurl, I., Koch, R., Kaser, A., Weiss, G., Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1. Blood Cells. Mol. Dis. 29:3 (2002), 488–497.
105. Meyron-Holtz, E.G., Ghosh, M.C., Rouault, T.A., Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science 306:5704 (2004), 2087–2090.
106. Pantopoulos, K., Porwal, S.K., Tartakoff, A., Devireddy, L., Mechanisms of mammalian iron homeostasis. Biochemistry 51:29 (2012), 5705–5724.
107. Muckenthaler, M.U., Galy, B., Hentze, M.W., Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28 (2008), 197–213.
108. Ludwiczek, S., Aigner, E., Theurl, I., Weiss, G., Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101:10 (2003), 4148–4154.
109. Devireddy, L.R., Gazin, C., Zhu, X., Green, M.R., A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123:7 (2005), 1293–1305.
110. Devireddy, L.R., Hart, D.O., Goetz, D.H., Green, M.R., A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell 141:6 (2010), 1006–1017.
111. Liu, Z., Ciocea, A., Devireddy, L., Endogenous siderophore 2, 5-dihydroxybenzoic acid deficiency promotes anemia and splenic iron overload in mice. Mol. Cell. Biol. 34:13 (2014), 2533–2546.
112. Bao, G., Clifton, M., Hoette, T.M., Mori, K., Deng, S.X., Qiu, A., Viltard, M., Williams, D., Paragas, N., Leete, T., Kulkarni, R., Li, X., Lee, B., Kalandadze, A., Ratner, A.J., Pizarro, J.C., Schmidt-Ott, K.M., Landry, D.W., Raymond, K.N., Strong, R.K., Barasch, J., Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat. Chem. Biol. 6:8 (2010), 602–609.
113. Nairz, M., Schroll, A., Demetz, E., Tancevski, I., Theurl, I., Weiss, G., ‘Ride on the ferrous wheel’-the cycle of iron in macrophages in health and disease. Immunobiology 220:2 (2015), 280–294.
114. Nairz, M., Theurl, I., Schroll, A., Theurl, M., Fritsche, G., Lindner, E., Seifert, M., Crouch, M.L., Hantke, K., Akira, S., Fang, F.C., Weiss, G., Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114:17 (2009), 3642–3651.
115. Drapier, J.C., Hibbs, J.B. Jr., Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J. Clin. Invest. 78:3 (1986), 790–797.
116. Drapier, J.C., Hirling, H., Wietzerbin, J., Kaldy, P., Kuhn, L.C., Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 12:9 (1993), 3643–3649.
117. Richardson, D.R., Neumannova, V., Nagy, E., Ponka, P., The effect of redox-related species of nitrogen monoxide on transferrin and iron uptake and cellular proliferation of erythroleukemia (K562) cells. Blood 86:8 (1995), 3211–3219.
118. Weiss, G., Werner-Felmayer, G., Werner, E.R., Grunewald, K., Wachter, H., Hentze, M.W., Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 180:3 (1994), 969–976.
119. Dlaska, M., Weiss, G., Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 162:10 (1999), 6171–6177.
120. Melillo, G., Taylor, L.S., Brooks, A., Musso, T., Cox, G.W., Varesio, L., Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272:18 (1997), 12236–12243.
121. Lok, H.C., Sahni, S., Jansson, P.J., Kovacevic, Z., Hawkins, C.L., Richardson, D.R., A nitric oxide storage and transport system that protects activated macrophages from endogenous nitric oxide cytotoxicity. J. Biol. Chem. 291:53 (2016), 27042–27061.
122. Nairz, M., Theurl, I., Swirski, F.K., Weiss, G., Pumping iron-how macrophages handle iron at the systemic, microenvironmental, and cellular levels. Pflugers Arch. 469:3–4 (2017), 397–418.
123. Weiss, S.J., The role of superoxide in the destruction of erythrocyte targets by human neutrophils. J. Biol. Chem. 255:20 (1980), 9912–9917.
124. Nakata, K., Saitoh, R., Amano, J., Koshiyama, A., Ichibangase, T., Murao, N., Ohta, K., Aso, Y., Ishigai, M., Imai, K., Alteration of intracellular secretory acute phase response proteins expressed in human hepatocyte induced by exposure with interleukin-6. Cytokine 59:2 (2012), 317–323.
125. Kristiansen, M., Graversen, J.H., Jacobsen, C., Sonne, O., Hoffman, H.J., Law, S.K., Moestrup, S.K., Identification of the haemoglobin scavenger receptor. Nature 409:6817 (2001), 198–201.
126. Schaer, D.J., Schaer, C.A., Buehler, P.W., Boykins, R.A., Schoedon, G., Alayash, A.I., Schaffner, A., CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 107:1 (2006), 373–380.
127. Stockwell, B.R., Friedmann Angeli, J.P., Bayir, H., Bush, A.I., Conrad, M., Dixon, S.J., Fulda, S., Gascon, S., Hatzios, S.K., Kagan, V.E., Noel, K., Jiang, X., Linkermann, A., Murphy, M.E., Overholtzer, M., Oyagi, A., Pagnussat, G.C., Park, J., Ran, Q., Rosenfeld, C.S., Salnikow, K., Tang, D., Torti, F.M., Torti, S.V., Toyokuni, S., Woerpel, K.A., Zhang, D.D., Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:2 (2017), 273–285.
128. Theurl, I., Hilgendorf, I., Nairz, M., Tymoszuk, P., Haschka, D., Asshoff, M., He, S., Gerhardt, L.M., Holderried, T.A., Seifert, M., Sopper, S., Fenn, A.M., Anzai, A., Rattik, S., McAlpine, C., Theurl, M., Wieghofer, P., Iwamoto, Y., Weber, G.F., Harder, N.K., Chousterman, B.G., Arvedson, T.L., McKee, M., Wang, F., Lutz, O.M., Rezoagli, E., Babitt, J.L., Berra, L., Prinz, M., Nahrendorf, M., Weiss, G., Weissleder, R., Lin, H.Y., Swirski, F.K., On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat. Med. 22:8 (2016), 945–951.
129. Haldar, M., Kohyama, M., So, A.Y., Kc, W., Wu, X., Briseno, C.G., Satpathy, A.T., Kretzer, N.M., Arase, H., Rajasekaran, N.S., Wang, L., Egawa, T., Igarashi, K., Baltimore, D., Murphy, T.L., Murphy, K.M., Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell 156:6 (2014), 1223–1234.
130. Mathieu, J.R., Heinis, M., Zumerle, S., Delga, S., Le Bon, A., Peyssonnaux, C., Investigating the real role of HIF-1 and HIF-2 in iron recycling by macrophages. Haematologica 99:7 (2016), e112–4.
131. Bleriot, C., Dupuis, T., Jouvion, G., Eberl, G., Disson, O., Lecuit, M., Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection. Immunity 42:1 (2014), 145–158.
132. Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S., Chora, A., Rodrigues, C.D., Gregoire, I.P., Cunha-Rodrigues, M., Portugal, S., Soares, M.P., Mota, M.M., Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 13:6 (2007), 703–710.
133. Lee, T.S., Chau, L.Y., Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8:3 (2002), 240–246.
134. Seixas, E., Gozzelino, R., Chora, A., Ferreira, A., Silva, G., Larsen, R., Rebelo, S., Penido, C., Smith, N.R., Coutinho, A., Soares, M.P., Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc. Natl. Acad. Sci. U. S. A. 106:37 (2009), 15837–15842.
135. Gozzelino, R., Andrade, B.B., Larsen, R., Luz, N.F., Vanoaica, L., Seixas, E., Coutinho, A., Cardoso, S., Rebelo, S., Poli, M., Barral-Netto, M., Darshan, D., Kuhn, L.C., Soares, M.P., Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe 12:5 (2014), 693–704.
136. Epiphanio, S., Mikolajczak, S.A., Goncalves, L.A., Pamplona, A., Portugal, S., Albuquerque, S., Goldberg, M., Rebelo, S., Anderson, D.G., Akinc, A., Vornlocher, H.P., Kappe, S.H., Soares, M.P., Mota, M.M., Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host Microbe 3:5 (2008), 331–338.
137. Sierra-Filardi, E., Vega, M.A., Sanchez-Mateos, P., Corbi, A.L., Puig-Kroger, A., Heme oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 215:9–10 (2010), 788–795.
138. Lokken, K.L., Mooney, J.P., Butler, B.P., Xavier, M.N., Chau, J.Y., Schaltenberg, N., Begum, R.H., Muller, W., Luckhart, S., Tsolis, R.M., Malaria parasite infection compromises control of concurrent systemic non-typhoidal Salmonella infection via IL-10-mediated alteration of myeloid cell function. PLoS Pathog., 10(5), 2014, e1004049.
139. Mitterstiller, A.M., Haschka, D., Dichtl, S., Nairz, M., Demetz, E., Talasz, H., Soares, M.P., Einwallner, E., Esterbauer, H., Fang, F.C., Geley, S., Weiss, G., Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection. Cell. Microbiol. 18:10 (2016), 1374–1389.
140. Paiva, C.N., Feijo, D.F., Dutra, F.F., Carneiro, V.C., Freitas, G.B., Alves, L.S., Mesquita, J., Fortes, G.B., Figueiredo, R.T., Souza, H.S., Fantappie, M.R., Lannes-Vieira, J., Bozza, M.T., Oxidative stress fuels Trypanosoma cruzi infection in mice. J. Clin. Invest. 122:7 (2012), 2531–2542.
141. Stijlemans, B., Vankrunkelsven, A., Brys, L., Magez, S., De Baetselier, P., Role of iron homeostasis in trypanosomiasis-associated anemia. Immunobiology 213:9–10 (2008), 823–835.
142. Cnops, J., De Trez, C., Stijlemans, B., Keirsse, J., Kauffmann, F., Barkhuizen, M., Keeton, R., Boon, L., Brombacher, F., Magez, S., NK-, NKT- and CD8-derived IFNgamma drives myeloid cell activation and erythrophagocytosis, resulting in trypanosomosis-associated acute anemia. PLoS Pathog., 11(6), 2015, e1004964.
143. Nemeth, E., Valore, E.V., Territo, M., Schiller, G., Lichtenstein, A., Ganz, T., Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:7 (2003), 2461–2463.
144. Millonig, G., Ganzleben, I., Peccerella, T., Casanovas, G., Brodziak-Jarosz, L., Breitkopf-Heinlein, K., Dick, T.P., Seitz, H.K., Muckenthaler, M.U., Mueller, S., Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). J. Biol. Chem. 287:44 (2012), 37472–37482.
145. Peyssonnaux, C., Zinkernagel, A.S., Datta, V., Lauth, X., Johnson, R.S., Nizet, V., TLR-4 dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107:9 (2006), 3727–3732.
146. Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B.K., Ganz, T., IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113:9 (2004), 1271–1276.
147. Rodriguez, R., Jung, C.L., Gabayan, V., Deng, J.C., Ganz, T., Nemeth, E., Bulut, Y., Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect. Immun. 82:2 (2014), 745–752.
148. Verga Falzacappa, M.V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M.W., Muckenthaler, M.U., STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109:1 (2007), 353–358.
149. Armitage, A.E., Eddowes, L.A., Gileadi, U., Cole, S., Spottiswoode, N., Selvakumar, T.A., Ho, L.P., Townsend, A.R., Drakesmith, H., Hepcidin regulation by innate immune and infectious stimuli. Blood 118:15 (2011), 4129–4139.
150. Sakamoto, K., Kim, Y.G., Hara, H., Kamada, N., Caballero-Flores, G., Tolosano, E., Soares, M.P., Puente, J.L., Inohara, N., Nunez, G., IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections. Sci. Immunol., 2(8), 2017 eaai8371.
151. Canali, S., Core, A.B., Zumbrennen-Bullough, K.B., Merkulova, M., Wang, C.Y., Schneyer, A.L., Pietrangelo, A., Babitt, J.L., Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: evidence for a role in hepcidin induction by inflammation in male mice. Endocrinology 157:3 (2016), 1146–1162.
152. Kanamori, Y., Murakami, M., Sugiyama, M., Hashimoto, O., Matsui, T., Funaba, M., Interleukin-1beta (IL-1beta) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein delta (C/EBPdelta) expression in hepatocytes. J. Biol. Chem. 292:24 (2017), 10275–10287.
153. Latour, C., Besson-Fournier, C., Gourbeyre, O., Meynard, D., Roth, M.P., Coppin, H., Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge. Blood 130:21 (2017), 2339–2343.
154. Spottiswoode, N., Armitage, A.E., Williams, A.R., Fyfe, A.J., Biswas, S., Hodgson, S.H., Llewellyn, D., Choudhary, P., Draper, S.J., Duffy, P.E., Drakesmith, H., Role of activins in hepcidin regulation during malaria. Infect. Immun. 85:12 (2017), e00191–17.
155. Theurl, I., Theurl, M., Seifert, M., Mair, S., Nairz, M., Rumpold, H., Zoller, H., Bellmann-Weiler, R., Niederegger, H., Talasz, H., Weiss, G., Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111:4 (2008), 2392–2399.
156. Pinto, J.P., Dias, V., Zoller, H., Porto, G., Carmo, H., Carvalho, F., de Sousa, M., Hepcidin messenger RNA expression in human lymphocytes. Immunology 130:2 (2010), 217–230.
157. Armitage, A.E., Lim, P.J., Frost, J.N., Pasricha, S.R., Soilleux, E.J., Evans, E., Morovat, A., Santos, A., Diaz, R., Biggs, D., Davies, B., Gileadi, U., Robbins, P.A., Lakhal-Littleton, S., Drakesmith, H., Induced disruption of the iron-regulatory hormone hepcidin inhibits acute inflammatory hypoferraemia. J. Innate Immun. 8:5 (2016), 517–528.
158. Liu, X.B., Nguyen, N.B., Marquess, K.D., Yang, F., Haile, D.J., Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells. Mol. Dis., 2005.
159. Yang, F., Liu, X.B., Quinones, M., Melby, P.C., Ghio, A., Haile, D.J., Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J. Biol. Chem. 277:42 (2002), 39786–39791.
160. Guida, C., Altamura, S., Klein, F.A., Galy, B., Boutros, M., Ulmer, A.J., Hentze, M.W., Muckenthaler, M.U., A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood 125:14 (2015), 2265–2275.
161. Potter, B.J., Blades, B., McHugh, T.A., Nunes, R.M., Beloqui, O., Slott, P.A., Rand, J.H., Effects of endotoxin on iron uptake by the hepatocyte. Am. J. Physiol. 57:4 Pt 1 (1989), G524–31.
162. Wigmore, S.J., Fearon, K.C., Maingay, J.P., Lai, P.B., Ross, J.A., Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am. J. Physiol. 73:4 Pt 1 (1997), E720–6.
163. Michels, K.R., Zhang, Z., Bettina, A.M., Cagnina, R.E., Stefanova, D., Burdick, M.D., Vaulont, S., Nemeth, E., Ganz, T., Mehrad, B., Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia. JCI Insight, 2(6), 2017, e92002.
164. Rooijakkers, S.H., Rasmussen, S.L., McGillivray, S.M., Bartnikas, T.B., Mason, A.B., Friedlander, A.M., Nizet, V., Human transferrin confers serum resistance against Bacillus anthracis. J. Biol. Chem. 285:36 (2010), 27609–27613.
165. Sebbane, F., Jarrett, C., Gardner, D., Long, D., Hinnebusch, B.J., Role of the Yersinia pestis yersiniabactin iron acquisition system in the incidence of flea-borne plague. PLoS One, 5(12), 2016, e14379.
166. Moalem, S., Percy, M.E., Kruck, T.P., Gelbart, R.R., Epidemic pathogenic selection: an explanation for hereditary hemochromatosis?. Med. Hypotheses 59:3 (2002), 325–329.
167. Bachman, M.A., Oyler, J.E., Burns, S.H., Caza, M., Lepine, F., Dozois, C.M., Weiser, J.N., Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect. Immun. 79:8 (2011), 3309–3316.
168. Brown, J.S., Gilliland, S.M., Ruiz-Albert, J., Holden, D.W., Characterization of pit a Streptococcus pneumoniae iron uptake ABC transporter. Infect. Immun. 70:8 (2002), 4389–4398.
169. Skaar, E.P., Humayun, M., Bae, T., DeBord, K.L., Schneewind, O., Iron-source preference of Staphylococcus aureus infections. Science 305:5690 (2004), 1626–1628.
170. Eichenbaum, Z., Muller, E., Morse, S.A., Scott, J.R., Acquisition of iron from host proteins by the group A streptococcus. Infect. Immun. 64:12 (1996), 5428–5429.
171. Romero-Espejel, M.E., Gonzalez-Lopez, M.A., Olivares-Trejo Jde, J., Streptococcus pneumoniae requires iron for its viability and expresses two membrane proteins that bind haemoglobin and haem. Metallomics 5:4 (2013), 384–389.
172. Nairz, M., Haschka, D., Demetz, E., Weiss, G., Iron at the interface of immunity and infection. Front. Pharmacol., 5, 2014, 152.
173. Weiss, G., Goodnough, L.T., Anemia of chronic disease. N. Engl. J. Med. 352:10 (2005), 1011–1023.
174. Figueiredo, R.T., Fernandez, P.L., Mourao-Sa, D.S., Porto, B.N., Dutra, F.F., Alves, L.S., Oliveira, M.F., Oliveira, P.L., Graca-Souza, A.V., Bozza, M.T., Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282:28 (2007), 20221–20229.
175. Dutra, F.F., Alves, L.S., Rodrigues, D., Fernandez, P.L., de Oliveira, R.B., Golenbock, D.T., Zamboni, D.S., Bozza, M.T., Hemolysis-induced lethality involves inflammasome activation by heme. Proc. Natl. Acad. Sci. U. S. A. 111:39 (2014), E4110–8.
176. Vinchi, F., Costa da Silva, M., Ingoglia, G., Petrillo, S., Brinkman, N., Zuercher, A., Cerwenka, A., Tolosano, E., Muckenthaler, M.U., Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease. Blood 127:4 (2016), 473–486.
177. van der Poll, T., van de Veerdonk, F.L., Scicluna, B.P., Netea, M.G., The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 17:7 (2017), 407–420.
178. Martins, R., Maier, J., Gorki, A.D., Huber, K.V., Sharif, O., Starkl, P., Saluzzo, S., Quattrone, F., Gawish, R., Lakovits, K., Aichinger, M.C., Radic-Sarikas, B., Lardeau, C.H., Hladik, A., Korosec, A., Brown, M., Vaahtomeri, K., Duggan, M., Kerjaschki, D., Esterbauer, H., Colinge, J., Eisenbarth, S.C., Decker, T., Bennett, K.L., Kubicek, S., Sixt, M., Superti-Furga, G., Knapp, S., Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions. Nat. Immunol. 17:12 (2016), 1361–1372.
179. Larsen, R., Gozzelino, R., Jeney, V., Tokaji, L., Bozza, F.A., Japiassu, A.M., Bonaparte, D., Cavalcante, M.M., Chora, A., Ferreira, A., Marguti, I., Cardoso, S., Sepulveda, N., Smith, A., Soares, M.P., A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med., 2(51), 2010 51ra71.
180. Sonnweber, T., Theurl, I., Seifert, M., Schroll, A., Eder, S., Mayer, G., Weiss, G., Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients. Nephrol. Dial. Transplant. 26:3 (2011), 977–987.
181. Zhang, Q., Lenardo, M.J., Baltimore, D., 30 years of NF-kappaB: a blossoming of relevance to human pathobiology. Cell 168:1–2 (2017), 37–57.
182. Ruddell, R.G., Hoang-Le, D., Barwood, J.M., Rutherford, P.S., Piva, T.J., Watters, D.J., Santambrogio, P., Arosio, P., Ramm, G.A., Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology 49:3 (2009), 887–900.
183. Kwak, E.L., Larochelle, D.A., Beaumont, C., Torti, S.V., Torti, F.M., Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J. Biol. Chem. 270:25 (1995), 15285–15293.
184. Oexle, H., Kaser, A., Most, J., Bellmann-Weiler, R., Werner, E.R., Werner-Felmayer, G., Weiss, G., Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J. Leukoc. Biol. 74:2 (2003), 287–294.
185. Kwon, S.J., Lee, G.T., Lee, J.H., Kim, W.J., Kim, I.Y., Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages. Immunology 28:Suppl. 1 (2009), e758–65.
186. Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A.S., Nizet, V., Johnson, R.S., Haddad, G.G., Karin, M., NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453:7196 (2008), 807–811.
187. Bandarra, D., Biddlestone, J., Mudie, S., Muller, H.A., Rocha, S., HIF-1alpha restricts NF-kappaB-dependent gene expression to control innate immunity signals. Dis Model Mech 8:2 (2015), 169–181.
188. Nizet, V., Johnson, R.S., Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9:9 (2009), 609–617.
189. Liu, F., Rehmani, I., Esaki, S., Fu, R., Chen, L., de Serrano, V., Liu, A., Pirin is an iron-dependent redox regulator of NF-kappaB. Proc. Natl. Acad. Sci. U. S. A. 110:24 (2013), 9722–9727.
190. Koury, M.J., Haase, V.H., Anaemia in kidney disease: harnessing hypoxia responses for therapy. Nat. Rev. Nephrol. 11:7 (2015), 394–410.
191. Siegert, I., Schodel, J., Nairz, M., Schatz, V., Dettmer, K., Dick, C., Kalucka, J., Franke, K., Ehrenschwender, M., Schley, G., Beneke, A., Sutter, J., Moll, M., Hellerbrand, C., Wielockx, B., Katschinski, D.M., Lang, R., Galy, B., Hentze, M.W., Koivunen, P., Oefner, P.J., Bogdan, C., Weiss, G., Willam, C., Jantsch, J., Ferritin-mediated iron sequestration stabilizes hypoxia-inducible factor-1alpha upon LPS activation in the presence of ample oxygen. Cell Rep. 13:10 (2015), 2048–2055.
192. Schatz, V., Strussmann, Y., Mahnke, A., Schley, G., Waldner, M., Ritter, U., Wild, J., Willam, C., Dehne, N., Brune, B., McNiff, J.M., Colegio, O.R., Bogdan, C., Jantsch, J., Myeloid cell-derived HIF-1alpha promotes control of leishmania major. J. Immunol. 197:10 (2016), 4034–4041.
193. Peyssonnaux, C., Datta, V., Cramer, T., Doedens, A., Theodorakis, E.A., Gallo, R.L., Hurtado-Ziola, N., Nizet, V., Johnson, R.S., HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115:7 (2005), 1806–1815.
194. Bennett, M.J., Lebron, J.A., Bjorkman, P.J., Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 403:6765 (2000), 46–53.
195. Drakesmith, H., Sweetland, E., Schimanski, L., Edwards, J., Cowley, D., Ashraf, M., Bastin, J., Townsend, A.R., The hemochromatosis protein HFE inhibits iron export from macrophages. Proc. Natl. Acad. Sci. U. S. A. 99:24 (2002), 15602–15607.
196. M. Nairz, G. Weiss, unpublished observations.
197. Wang, L., Johnson, E.E., Shi, H.N., Walker, W.A., Wessling-Resnick, M., Cherayil, B.J., Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J. Immunol. 181:4 (2008), 2723–2731.
198. Koening, C.L., Miller, J.C., Nelson, J.M., Ward, D.M., Kushner, J.P., Bockenstedt, L.K., Weis, J.J., Kaplan, J., De Domenico, I., Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi. Blood 114:9 (2009), 1913–1918.
199. Peyssonnaux, C., Zinkernagel, A.S., Datta, V., Lauth, X., Johnson, R.S., Nizet, V., TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107:9 (2006), 3727–3732.
200. De Domenico, I., Zhang, T.Y., Koening, C.L., Branch, R.W., London, N., Lo, E., Daynes, R.A., Kushner, J.P., Li, D., Ward, D.M., Kaplan, J., Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest. 120:7 (2010), 2395–2405.
201. Pagani, A., Nai, A., Corna, G., Bosurgi, L., Rovere-Querini, P., Camaschella, C., Silvestri, L., Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood 118:3 (2011), 736–746.
202. Weiss, G., Fuchs, D., Hausen, A., Reibnegger, G., Werner, E.R., Werner-Felmayer, G., Wachter, H., Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp. Hematol. 20:5 (1992), 605–610.
203. Mencacci, A., Cenci, E., Boelaert, J.R., Bucci, P., Mosci, P., Fe d'Ostiani, C., Bistoni, F., Romani, L., Iron overload alters innate and T helper cell responses to Candida albicans in mice. J. Infect. Dis. 175:6 (1997), 1467–1476.
204. Abbas, K., Breton, J., Planson, A.G., Bouton, C., Bignon, J., Seguin, C., Riquier, S., Toledano, M.B., Drapier, J.C., Nitric oxide activates an Nrf2/sulfiredoxin antioxidant pathway in macrophages. Free Radic. Biol. Med. 51:1 (2011), 107–114.
205. Ohtsuji, M., Katsuoka, F., Kobayashi, A., Aburatani, H., Hayes, J.D., Yamamoto, M., Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J. Biol. Chem. 283:48 (2008), 33554–33562.
206. Dhakshinamoorthy, S., Jain, A.K., Bloom, D.A., Jaiswal, A.K., Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J. Biol. Chem. 280:17 (2005), 16891–16900.
207. Harada, N., Kanayama, M., Maruyama, A., Yoshida, A., Tazumi, K., Hosoya, T., Mimura, J., Toki, T., Maher, J.M., Yamamoto, M., Itoh, K., Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch. Biochem. Biophys. 508:1 (2011), 101–109.
208. Pietsch, E.C., Chan, J.Y., Torti, F.M., Torti, S.V., Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones. J. Biol. Chem. 278:4 (2003), 2361–2369.
209. Weiss, G., Carver, P.L., Role of divalent metals in infectious disease susceptibility and outcome. Clinical Microbiol. Infect.: Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 24:1 (2018), 16–23.
210. Weinberg, E.D., Iron availability and infection. Biochim. Biophys. Acta 1790:7 (2009), 600–605.
211. Drakesmith, H., Prentice, A.M., Hepcidin and the iron-infection axis. Science 338:6108 (2012), 768–772.
212. Cassat, J.E., Skaar, E.P., Iron in infection and immunity. Cell Host Microbe 13:5 (2013), 509–519.
213. Ganz, T., Nemeth, E., Iron homeostasis in host defence and inflammation. Nat. Rev. Immunol. 15:8 (2015), 500–510.
214. Soares, M.P., Weiss, G., The Iron age of host-microbe interactions. EMBO Rep. 16:11 (2015), 1482–1500.
215. Schaible, U.E., Kaufmann, S.H., Iron and microbial infection. Nat. Rev. Microbiol. 2:12 (2004), 946–953.
216. Posey, J.E., Gherardini, F.C., Lack of a role for iron in the Lyme disease pathogen. Science 288:5471 (2000), 1651–1653.
217. Vento, S., Cainelli, F., Cesario, F., Infections and thalassaemia. Lancet Infect. Dis. 6:4 (2006), 226–233.
218. Gardenghi, S., Marongiu, M.F., Ramos, P., Guy, E., Breda, L., Chadburn, A., Liu, Y., Amariglio, N., Rechavi, G., Rachmilewitz, E.A., Breuer, W., Cabantchik, Z.I., Wrighting, D.M., Andrews, N.C., de Sousa, M., Giardina, P.J., Grady, R.W., Rivella, S., Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109:11 (2007), 5027–5035.
219. Wang, S.C., Lin, K.H., Chern, J.P., Lu, M.Y., Jou, S.T., Lin, D.T., Lin, K.S., Severe bacterial infection in transfusion-dependent patients with thalassemia major. Clin. Infect. Dis. 37:7 (2003), 984–988.
220. Arezes, J., Jung, G., Gabayan, V., Valore, E., Ruchala, P., Gulig, P.A., Ganz, T., Nemeth, E., Bulut, Y., Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17:1 (2015), 47–57.
221. Wermke, M., Schmidt, A., Middeke, J.M., Sockel, K., von Bonin, M., Schonefeldt, C., Mair, S., Plodeck, V., Laniado, M., Weiss, G., Schetelig, J., Ehninger, G., Theurl, I., Bornhauser, M., Platzbecker, U., MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation. Clin. Cancer Res. 18:23 (2012), 6460–6468.
222. Storey, J.A., Connor, R.F., Lewis, Z.T., Hurd, D., Pomper, G., Keung, Y.K., Grover, M., Lovato, J., Torti, S.V., Torti, F.M., Molnar, I., The transplant iron score as a predictor of stem cell transplant survival. J. Hematol. Oncol., 2, 2009, 44.
223. Ascenzi, P., Bocedi, A., Visca, P., Altruda, F., Tolosano, E., Beringhelli, T., Fasano, M., Hemoglobin and heme scavenging. IUBMB Life 57:11 (2005), 749–759.
224. Hvidberg, V., Maniecki, M.B., Jacobsen, C., Hojrup, P., Moller, H.J., Moestrup, S.K., Identification of the receptor scavenging hemopexin-heme complexes. Blood 106:7 (2005), 2572–2579.
225. Weiss, G., Modification of iron regulation by the inflammatory response. Best Pract. Res. Clin. Haematol. 18:2 (2005), 183–201.
226. Meyron-Holtz, E.G., Moshe-Belizowski, S., Cohen, L.A., A possible role for secreted ferritin in tissue iron distribution. J. Neural Transm. (Vienna) 118:3 (2011), 337–347.
227. Flo, T.H., Smith, K.D., Sato, S., Rodriguez, D.J., Holmes, M.A., Strong, R.K., Akira, S., Aderem, A., Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:7019 (2004), 917–921.
228. Bachman, M.A., Lenio, S., Schmidt, L., Oyler, J.E., Weiser, J.N., Interaction of lipocalin 2 transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia. MBio 3:6 (2012), e00224–11.
229. Smith, K.D., Iron metabolism at the host pathogen interface: lipocalin 2 and the pathogen-associated iroA gene cluster. Int. J. Biochem. Cell Biol. 39:10 (2007), 1776–1780.
230. Kingsley, R.A., Reissbrodt, R., Rabsch, W., Ketley, J.M., Tsolis, R.M., Everest, P., Dougan, G., Baumler, A.J., Roberts, M., Williams, P.H., Ferrioxamine-mediated Iron(III) utilization by Salmonella enterica. Appl. Environ. Microbiol. 65:4 (1999), 1610–1618.
231. Holden, V.I., Bachman, M.A., Diverging roles of bacterial siderophores during infection. Metallomics 7:6 (2015), 986–995.
232. Behnsen, J., Raffatellu, M., Siderophores more than stealing iron. MBio 7:6 (2016), e01906–16.
233. Haas, H., Molecular genetics of fungal siderophore biosynthesis and uptake: the role of siderophores in iron uptake and storage. Appl. Microbiol. Biotechnol. 62:4 (2003), 316–330.
234. Schrettl, M., Bignell, E., Kragl, C., Joechl, C., Rogers, T., Arst, H.N. Jr., Haynes, K., Haas, H., Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J. Exp. Med. 200:9 (2004), 1213–1219.
235. Schrettl, M., Bignell, E., Kragl, C., Sabiha, Y., Loss, O., Eisendle, M., Wallner, A., Arst, H.N. Jr., Haynes, K., Haas, H., Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection. PLoS Pathog. 3:9 (2007), 1195–1207.
236. Seifert, M., Nairz, M., Schroll, A., Schrettl, M., Haas, H., Weiss, G., Effects of the Aspergillus fumigatus siderophore systems on the regulation of macrophage immune effector pathways and iron homeostasis. Immunobiology 213:9–10 (2008), 767–778.
237. Singh, V., Yeoh, B.S., Xiao, X., Kumar, M., Bachman, M., Borregaard, N., Joe, B., Vijay-Kumar, M., Interplay between enterobactin, myeloperoxidase and lipocalin 2 regulates E. coli survival in the inflamed gut. Nat. Commun., 6, 2015, 7113.
238. Schroll, A., Eller, K., Feistritzer, C., Nairz, M., Sonnweber, T., Moser, P.A., Rosenkranz, A.R., Theurl, I., Weiss, G., Lipocalin-2 ameliorates granulocyte functionality. Eur. J. Immunol. 42:12 (2012), 3346–3357.
239. Liu, Z., Petersen, R., Devireddy, L., Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections. J. Immunol. 190:9 (2013), 4692–4706.
240. Bachman, M.A., Miller, V.L., Weiser, J.N., Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog., 5(10), 2009, e1000622.
241. Nairz, M., Schroll, A., Haschka, D., Dichtl, S., Sonnweber, T., Theurl, I., Theurl, M., Lindner, E., Demetz, E., Asshoff, M., Bellmann-Weiler, R., Muller, R., Gerner, R.R., Moschen, A.R., Baumgartner, N., Moser, P.L., Talasz, H., Tilg, H., Fang, F.C., Weiss, G., Lipocalin-2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response. Eur. J. Immunol. 45:11 (2015), 3073–3086.
242. Zhao, H., Konishi, A., Fujita, Y., Yagi, M., Ohata, K., Aoshi, T., Itagaki, S., Sato, S., Narita, H., Abdelgelil, N.H., Inoue, M., Culleton, R., Kaneko, O., Nakagawa, A., Horii, T., Akira, S., Ishii, K.J., Coban, C., Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism. Cell Host Microbe 12:5 (2012), 705–716.
243. Warszawska, J.M., Gawish, R., Sharif, O., Sigel, S., Doninger, B., Lakovits, K., Mesteri, I., Nairz, M., Boon, L., Spiel, A., Fuhrmann, V., Strobl, B., Muller, M., Schenk, P., Weiss, G., Knapp, S., Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J. Clin. Invest. 123:8 (2013), 3363–3372.
244. Eller, K., Schroll, A., Banas, M., Kirsch, A.H., Huber, J.M., Nairz, M., Skvortsov, S., Weiss, G., Rosenkranz, A.R., Theurl, I., Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritis. PLoS One, 8(7), 2013, e67693.
245. Goetz, D.H., Holmes, M.A., Borregaard, N., Bluhm, M.E., Raymond, K.N., Strong, R.K., The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10:5 (2002), 1033–1043.
246. Berger, T., Togawa, A., Duncan, G.S., Elia, A.J., You-Ten, A., Wakeham, A., Fong, H.E., Cheung, C.C., Mak, T.W., Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 103:6 (2006), 1834–1839.
247. Fischbach, M.A., Lin, H., Liu, D.R., Walsh, C.T., In vitro characterization of IroB a pathogen-associated C-glycosyltransferase. Proc. Natl. Acad. Sci. U. S. A. 102:3 (2005), 571–576.
248. Crouch, M.L., Castor, M., Karlinsey, J.E., Kalhorn, T., Fang, F.C., Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol. Microbiol. 67:5 (2008), 971–983.
249. Hantke, K., Nicholson, G., Rabsch, W., Winkelmann, G., Salmochelins siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc. Natl. Acad. Sci. U. S. A. 100:7 (2003), 3677–3682.
250. Peek, M.E., Bhatnagar, A., McCarty, N.A., Zughaier, S.M., Pyoverdine, the major siderophore in Pseudomonas aeruginosa, evades NGAL recognition. Interdiscip. Perspect. Infect. Dis., 2012, 843509.
251. Saha, P., Yeoh, B.S., Olvera, R.A., Xiao, X., Singh, V., Awasthi, D., Subramanian, B.C., Chen, Q., Dikshit, M., Wang, Y., Parent, C.A., Vijay-Kumar, M., Bacterial siderophores hijack neutrophil functions. J. Immunol. 198:11 (2017), 4293–4303.
252. Deriu, E., Liu, J.Z., Pezeshki, M., Edwards, R.A., Ochoa, R.J., Contreras, H., Libby, S.J., Fang, F.C., Raffatellu, M., Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14:1 (2013), 26–37.
253. Moschen, A.R., Gerner, R.R., Wang, J., Klepsch, V., Adolph, T.E., Reider, S.J., Hackl, H., Pfister, A., Schilling, J., Moser, P.L., Kempster, S.L., Swidsinski, A., Orth Holler, D., Weiss, G., Baines, J.F., Kaser, A., Tilg, H., Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations. Cell Host Microbe 19:4 (2016), 455–469.
254. Quenee, L.E., Hermanas, T.M., Ciletti, N., Louvel, H., Miller, N.C., Elli, D., Blaylock, B., Mitchell, A., Schroeder, J., Krausz, T., Kanabrocki, J., Schneewind, O., Hereditary hemochromatosis restores the virulence of plague vaccine strains. J. Infect. Dis. 206:7 (2012), 1050–1058.
255. Stefanova, D., Raychev, A., Arezes, J., Ruchala, P., Gabayan, V., Skurnik, M., Dillon, B.J., Horwitz, M.A., Ganz, T., Bulut, Y., Nemeth, E., Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron. Blood 130:3 (2017), 245–257.
256. Ley, V., Andrews, N.W., Robbins, E.S., Nussenzweig, V., Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells. J. Exp. Med. 168:2 (1988), 649–659.
257. Mair, S.M., Nairz, M., Bellmann-Weiler, R., Muehlbacher, T., Schroll, A., Theurl, I., Moser, P.L., Talasz, H., Fang, F.C., Weiss, G., Nifedipine affects the course of Salmonella enterica serovar Typhimurium infection by modulating macrophage iron homeostasis. J. Infect. Dis. 204:5 (2012), 685–694.
258. Zhang, Z., Zhang, F., An, P., Guo, X., Shen, Y., Tao, Y., Wu, Q., Zhang, Y., Yu, Y., Ning, B., Nie, G., Knutson, M.D., Anderson, G.J., Wang, F., Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood 118:7 (2011), 1912–1922.
259. Paradkar, P.N., De Domenico, I., Durchfort, N., Zohn, I., Kaplan, J., Ward, D.M., Iron depletion limits intracellular bacterial growth in macrophages. Blood 112:3 (2008), 866–874.
260. Johnson, E.E., Sandgren, A., Cherayil, B.J., Murray, M., Wessling-Resnick, M., Role of ferroportin in macrophage-mediated immunity. Infect. Immun. 78:12 (2010), 5099–5106.
261. Chlosta, S., Fishman, D.S., Harrington, L., Johnson, E.E., Knutson, M.D., Wessling-Resnick, M., Cherayil, B.J., The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 74:5 (2006), 3065–3067.
262. Liu, D., Gan, Z.S., Ma, W., Xiong, H.T., Li, Y.Q., Wang, Y.Z., Du, H.H., Synthetic porcine hepcidin exhibits different roles in Escherichia coli and Salmonella infections. Antimicrob. Agents Chemother., 61(10), 2017 AAC. 02638-16.
263. Bellmann-Weiler, R., Schroll, A., Engl, S., Nairz, M., Talasz, H., Seifert, M., Weiss, G., Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis. Immunobiology 218:7 (2013), 969–978.
264. Haschka, D., Nairz, M., Demetz, E., Wienerroither, S., Decker, T., Weiss, G., Contrasting regulation of macrophage iron homeostasis in response to infection with Listeria monocytogenes depending on localization of bacteria. Metallomics 7:6 (2015), 1036–1045.
265. Nairz, M., Theurl, I., Ludwiczek, S., Theurl, M., Mair, S.M., Fritsche, G., Weiss, G., The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell. Microbiol. 9:9 (2007), 2126–2140.
266. Nairz, M., Schleicher, U., Schroll, A., Sonnweber, T., Theurl, I., Ludwiczek, S., Talasz, H., Brandacher, G., Moser, P.L., Muckenthaler, M.U., Fang, F.C., Bogdan, C., Weiss, G., Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J. Exp. Med. 210:5 (2013), 855–873.
267. Willemetz, A., Beatty, S., Richer, E., Rubio, A., Auriac, A., Milkereit, R.J., Thibaudeau, O., Vaulont, S., Malo, D., Canonne-Hergaux, F., Iron- and hepcidin-independent downregulation of the iron exporter ferroportin in macrophages during Salmonella infection. Front. Immunol., 8, 2017, 498.
268. Brown, D.E., Nick, H.J., McCoy, M.W., Moreland, S.M., Stepanek, A.M., Benik, R., O'Connell, K.E., Pilonieta, M.C., Nagy, T.A., Detweiler, C.S., Increased ferroportin-1 expression and rapid splenic iron loss occur with anemia caused by Salmonella enterica Serovar Typhimurium infection in mice. Infect. Immun. 83:6 (2015), 2290–2299.
269. Nairz, M., Schroll, A., Haschka, D., Dichtl, S., Tymoszuk, P., Demetz, E., Moser, P., Haas, H., Fang, F.C., Theurl, I., Weiss, G., Genetic and dietary iron overload differentially affect the course of Salmonella typhimurium infection. Front. Cell. Infect. Microbiol., 7, 2017, 110.
270. Moreira, A.C., Neves, J.V., Silva, T., Oliveira, P., Gomes, M.S., Rodrigues, P.N., Hepcidin-(in)dependent mechanisms of iron metabolism regulation during infection by Listeria and Salmonella. Infect. Immun., 85(9), 2017 IAI. 00353-17.
271. Agoro, R., Benmerzoug, S., Rose, S., Bouyer, M., Gozzelino, R., Garcia, I., Ryffel, B., Quesniaux, V.F.J., Mura, C., An iron-rich diet decreases the mycobacterial burden and correlates with hepcidin upregulation lower levels of proinflammatory mediators, and increased T-cell recruitment in a model of Mycobacterium bovis Bacille Calmette-Guerin infection. J. Infect. Dis. 216:7 (2017), 907–918.
272. Sow, F.B., Florence, W.C., Satoskar, A.R., Schlesinger, L.S., Zwilling, B.S., Lafuse, W.P., Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J. Leukoc. Biol. 82:4 (2007), 934–945.
273. Forbes, J.R., Gros, P., Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol. 9:8 (2001), 397–403.
274. Blackwell, J.M., Searle, S., Mohamed, H., White, J.K., Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol. Lett. 85:2 (2003), 197–203.
275. Fritsche, G., Dlaska, M., Barton, H., Theurl, I., Garimorth, K., Weiss, G., Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression. J. Immunol. 171:4 (2003), 1994–1998.
276. Fritsche, G., Nairz, M., Libby, S.J., Fang, F.C., Weiss, G., Slc11a1 (Nramp1) impairs growth of Salmonella enterica serovar typhimurium in macrophages via stimulation of lipocalin-2 expression. J. Leukoc. Biol. 92:2 (2012), 353–359.
277. Fritsche, G., Nairz, M., Theurl, I., Mair, S., Bellmann-Weiler, R., Barton, H.C., Weiss, G., Modulation of macrophage iron transport by Nramp1 (Slc11a1). Immunobiology 212:9–10 (2007), 751–757.
278. Fritsche, G., Nairz, M., Werner, E.R., Barton, H.C., Weiss, G., Nramp1-functionality increases iNOS expression via repression of IL-10 formation. Eur. J. Immunol. 38:11 (2008), 3060–3067.
279. Bellamy, R., Ruwende, C., Corrah, T., McAdam, K.P., Whittle, H.C., Hill, A.V., Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338:10 (1998), 640–644.
280. Archer, N.S., Nassif, N.T., O'Brien, B.A., Genetic variants of SLC11A1 are associated with both autoimmune and infectious diseases: systematic review and meta-analysis. Genes Immun. 16:4 (2015), 275–283.
281. Soe-Lin, S., Apte, S.S., Andriopoulos, B. Jr., Andrews, M.C., Schranzhofer, M., Kahawita, T., Garcia-Santos, D., Ponka, P., Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc. Natl. Acad. Sci. U. S. A. 106:14 (2009), 5960–5965.
282. Huynh, C., Sacks, D.L., Andrews, N.W., A Leishmania amazonensis ZIP family iron transporter is essential for parasite replication within macrophage phagolysosomes. J. Exp. Med. 203:10 (2006), 2363–2375.
283. Huynh, C., Yuan, X., Miguel, D.C., Renberg, R.L., Protchenko, O., Philpott, C.C., Hamza, I., Andrews, N.W., Heme uptake by Leishmania amazonensis is mediated by the transmembrane protein LHR1. PLoS Pathog., 8(7), 2012, e1002795.
284. Das, N.K., Biswas, S., Solanki, S., Mukhopadhyay, C.K., Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. Cell. Microbiol. 11:1 (2009), 83–94.
285. Kim, D.K., Jeong, J.H., Lee, J.M., Kim, K.S., Park, S.H., Kim, Y.D., Koh, M., Shin, M., Jung, Y.S., Kim, H.S., Lee, T.H., Oh, B.C., Kim, J.I., Park, H.T., Jeong, W.I., Lee, C.H., Park, S.B., Min, J.J., Jung, S.I., Choi, S.Y., Choy, H.E., Choi, H.S., Inverse agonist of estrogen-related receptor gamma controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 20:4 (2014), 419–424.
286. Fang, F.C., Weiss, G., Iron ERRs with Salmonella. Cell Host Microbe 15:5 (2014), 515–516.
287. Olliaro, P.L., Goldberg, D.E., The plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol. Today 11:8 (1995), 294–297.
288. Clark, M., Fisher, N.C., Kasthuri, R., Cerami Hand, C., Parasite maturation and host serum iron influence the labile iron pool of erythrocyte stage Plasmodium falciparum. Br. J. Haematol. 161:2 (2013), 262–269.
289. Portugal, S., Drakesmith, H., Mota, M.M., Superinfection in malaria: Plasmodium shows its iron will. EMBO Rep. 12:12 (2011), 1233–1242.
290. Gordeuk, V.R., Thuma, P.E., McLaren, C.E., Biemba, G., Zulu, S., Poltera, A.A., Askin, J.E., Brittenham, G.M., Transferrin saturation and recovery from coma in cerebral malaria. Blood 85:11 (1995), 3297–3301.
291. Gwamaka, M., Kurtis, J.D., Sorensen, B.E., Holte, S., Morrison, R., Mutabingwa, T.K., Fried, M., Duffy, P.E., Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin. Infect. Dis. 54:8 (2012), 1137–1144.
292. Koka, S., Foller, M., Lamprecht, G., Boini, K.M., Lang, C., Huber, S.M., Lang, F., Iron deficiency influences the course of malaria in Plasmodium berghei infected mice. Biochem. Biophys. Res. Commun. 357:3 (2007), 608–614.
293. de Mast, Q., Syafruddin, D., Keijmel, S., Riekerink, T.O., Deky, O., Asih, P.B., Swinkels, D.W., van der Ven, A.J., Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica 95:7 (2010), 1068–1074.
294. Portugal, S., Carret, C., Recker, M., Armitage, A.E., Goncalves, L.A., Epiphanio, S., Sullivan, D., Roy, C., Newbold, C.I., Drakesmith, H., Mota, M.M., Host-mediated regulation of superinfection in malaria. Nat. Med. 17:6 (2011), 732–737.
295. Wang, H.Z., He, Y.X., Yang, C.J., Zhou, W., Zou, C.G., Hepcidin is regulated during blood-stage malaria and plays a protective role in malaria infection. J. Immunol. 187:12 (2011), 6410–6416.
296. Fang, F.C., Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2:10 (2004), 820–832.
297. Krause, C.D., He, W., Kotenko, S., Pestka, S., Modulation of the activation of Stat1 by the interferon-gamma receptor complex. Cell Res. 16:1 (2006), 113–123.
298. Bogdan, C., Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 36:3 (2015), 161–178.
299. Nairz, M., Fritsche, G., Brunner, P., Talasz, H., Hantke, K., Weiss, G., Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immunol. 38:7 (2008), 1923–1936.
300. Wu, Q., Shen, Y., Tao, Y., Wei, J., Wang, H., An, P., Zhang, Z., Gao, H., Zhou, T., Wang, F., Min, J., Hemojuvelin regulates the innate immune response to peritoneal bacterial infection in mice. Cell Discov 3 (2017), 17028–17041.
301. Byrd, T.F., Horwitz, M.A., Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 83:5 (1989), 1457–1465.
302. Zhong, W., Lafuse, W.P., Zwilling, B.S., Infection with Mycobacterium avium differentially regulates the expression of iron transport protein mRNA in murine peritoneal macrophages. Infect. Immun. 69:11 (2001), 6618–6624.
303. Dowdle, W.E., Nyfeler, B., Nagel, J., Elling, R.A., Liu, S., Triantafellow, E., Menon, S., Wang, Z., Honda, A., Pardee, G., Cantwell, J., Luu, C., Cornella-Taracido, I., Harrington, E., Fekkes, P., Lei, H., Fang, Q., Digan, M.E., Burdick, D., Powers, A.F., Helliwell, S.B., D'Aquin, S., Bastien, J., Wang, H., Wiederschain, D., Kuerth, J., Bergman, P., Schwalb, D., Thomas, J., Ugwonali, S., Harbinski, F., Tallarico, J., Wilson, C.J., Myer, V.E., Porter, J.A., Bussiere, D.E., Finan, P.M., Labow, M.A., Mao, X., Hamann, L.G., Manning, B.D., Valdez, R.A., Nicholson, T., Schirle, M., Knapp, M.S., Keaney, E.P., Murphy, L.O., Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat. Cell Biol. 16:11 (2014), 1069–1079.
304. Bellelli, R., Federico, G., Matte, A., Colecchia, D., Iolascon, A., Chiariello, M., Santoro, M., De Franceschi, L., Carlomagno, F., NCOA4 deficiency impairs systemic iron homeostasis. Cell Rep. 14:3 (2016), 411–421.
305. Birmingham, C.L., Smith, A.C., Bakowski, M.A., Yoshimori, T., Brumell, J.H., Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281:16 (2006), 11374–11383.
306. Truman-Rosentsvit, M., Berenbaum, D., Spektor, L., Cohen, L.A., Belizowsky-Moshe, S., Lifshitz, L., Ma, J., Li, W., Kesselman, E., Abutbul-Ionita, I., Danino, D., Gutierrez, L., Li, H., Li, K., Lou, H., Regoni, M., Poli, M., Glaser, F., Rouault, T.A., Meyron-Holtz, E.G., Ferritin is secreted via 2 distinct nonclassical vesicular pathways. Blood 131:3 (2018), 342–352.
307. Nairz, M., Theurl, I., Wolf, D., Weiss, G., Iron deficiency or anemia of inflammation? Differential diagnosis and mechanisms of anemia of inflammation. Wien. Med. Wochenschr. 166:13–14 (2016), 411–423.
308. Theurl, M., Nairz, M., Schroll, A., Sonnweber, T., Asshoff, M., Haschka, D., Seifert, M., Willenbacher, W., Wilflingseder, D., Posch, W., Murphy, A.T., Witcher, D.R., Theurl, I., Weiss, G., Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats. Haematologica 99:9 (2014), 1516–1524.
309. Theurl, I., Schroll, A., Sonnweber, T., Nairz, M., Theurl, M., Willenbacher, W., Eller, K., Wolf, D., Seifert, M., Sun, C.C., Babitt, J.L., Hong, C.C., Menhall, T., Gearing, P., Lin, H.Y., Weiss, G., Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 118:18 (2011), 4977–4984.
310. Sun, C.C., Vaja, V., Chen, S., Theurl, I., Stepanek, A., Brown, D.E., Cappellini, M.D., Weiss, G., Hong, C.C., Lin, H.Y., Babitt, J.L., A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Nephrol. Dial. Transplant. 28:7 (2013), 1733–1743.
311. Sasu, B.J., Cooke, K.S., Arvedson, T.L., Plewa, C., Ellison, A.R., Sheng, J., Winters, A., Juan, T., Li, H., Begley, C.G., Molineux, G., Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 115:17 (2010), 3616–3624.
312. Stauder, R., Valent, P., Theurl, I., Anemia at older age: etiologies, clinical implications and management. Blood 131:5 (2018), 505–514.
313. Ibrahim, A.S., Edwards, J.E. Jr., Fu, Y., Spellberg, B., Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J. Antimicrob. Chemother. 58:5 (2006), 1070–1073.
314. Ibrahim, A.S., Gebermariam, T., Fu, Y., Lin, L., Husseiny, M.I., French, S.W., Schwartz, J., Skory, C.D., Edwards, J.E. Jr., Spellberg, B.J., The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J. Clin. Invest. 117:9 (2007), 2649–2657.
315. Spellberg, B., Ibrahim, A.S., Chin-Hong, P.V., Kontoyiannis, D.P., Morris, M.I., Perfect, J.R., Fredricks, D., Brass, E.P., The Deferasirox-amBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized double-blinded, placebo-controlled trial. J. Antimicrob. Chemother. 67:3 (2012), 715–722.
316. Deschemin, J.C., Noordine, M.L., Remot, A., Willemetz, A., Afif, C., Canonne-Hergaux, F., Langella, P., Karim, Z., Vaulont, S., Thomas, M., Nicolas, G., The microbiota shifts the iron sensing of intestinal cells. FASEB J. 30:1 (2016), 252–261.
317. Shanmugam, N.K., Chen, K., Cherayil, B.J., Commensal bacteria-induced interleukin 1beta (IL-1beta) secreted by macrophages up-regulates hepcidin expression in hepatocytes by activating the bone morphogenetic protein signaling pathway. J. Biol. Chem. 290:51 (2015), 30637–30647.
318. Dichtl, S., Haschka, D., Nairz, M., Seifert, M., Volani, C., Lutz, O., Weiss, G., Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages. Biochem. Pharmacol. 148 (2018), 193–201.
319. Atkinson, S.H., Uyoga, S.M., Armitage, A.E., Khandwala, S., Mugyenyi, C.K., Bejon, P., Marsh, K., Beeson, J.G., Prentice, A.M., Drakesmith, H., Williams, T.N., Malaria and age variably but critically control hepcidin throughout childhood in Kenya. EBioMedicine 2:10 (2015), 1478–1486.